/

Società

Ar

Non verificato

Arrakis Therapeutics

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaIndustriaSalute

2 comunicati stampa

Guarda tutti i comunicati

10/03/2025

Eventi

Fiere

Industria

Salute

Biotecnologia

Medicina - Varie

Scienza

Farmaceutica

Arrakis Therapeutics Announces Oral Presentation Describing RNA-targeted Small Molecule to Treat Myotonic Dystrophy at MDA Conference 2025

Fonte

Arrakis Therapeutics

Emittente

1.00

0

04/12/2024

Eventi

Industria

Biotecnologia

Salute

Farmaceutica

Medicina - Varie

Arrakis Therapeutics Unveils Data for its Lead, Rationally Designed, RNA-Targeted Small Molecule (rSM) Drug Program Demonstrating Disease-Modifying Binding to RNA to Treat Myotonic Dystrophy

Fonte

Arrakis Therapeutics

Emittente

1.00

0

Seguaci

0

Compatibilità

0